Skip to main content
Clinical Trials/CTRI/2022/09/045142
CTRI/2022/09/045142
Not yet recruiting
Phase 2

Clinical Study to Evaluate the Immunomodulatory Effect of Balchaturbhadra Syrup in lowering down Morbidity of Children

niversity Post Graduate Institute of Ayurved Studies and Research DSRRAU Jodhpur0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Post Graduate Institute of Ayurved Studies and Research DSRRAU Jodhpur
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
niversity Post Graduate Institute of Ayurved Studies and Research DSRRAU Jodhpur

Eligibility Criteria

Inclusion Criteria

  • 1 Children age group from 1 Year to 05 years.
  • 2\.Children having recurrent URTI.
  • 3\.Children having recurrent GIT Disease.
  • 4\.Children having other recurrent disease.

Exclusion Criteria

  • 1\.Children age below 1 year \& above 05 years of age.
  • 2\.Children having history of hypersensitivity to trial drug or their ingredient.
  • 3\.Children who have completed participation in any trial drug past 6 months.
  • 4\.Children those having chronic respiratory illness like tuberculosis, pleural effusion, bronchiectasis, lung carcinoma, COPD and Chronic lung disease will be excluded.
  • 5\.Children those having chronic GIT disorders like abdominal tuberculosis, chronic ailments and any tumors will be excluded.
  • 6\.Children having Diabetes Mellitus, any malignant conditions, genetic disorders and congenital disorders will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials